Vall d'Hebron Institut de Recerca

@VHIR_ · Barcelona (Catalonia, Spain) · joined 15 Nov 2010

La #recerca d'avui, la #salut del demà. The research of today, the health of tomorrow. @iCERCA centre

23 091Followers

1 358Following

27 342Posts total

2.4KViews on collected posts

Son gönderiler

Vall d'Hebron Institut de Recerca@VHIR_7 Sep

. @vallhebron i @VivaDiagnostics estudiaran el potencial de biomarcadors funcionals NLRP3 per anticipar la resposta terapèutica en esclerosi múltiple. El treball utilitzarà mostres de pacients amb la malaltia i de controls sans. Més info: https://t.co/Xu8wGi0mTX https://t.co/bKL

417 views · 2 likes · 0 reposts · 0 replies Open on X →

Vall d'Hebron Institut de Recerca@VHIR_4 Sep

El Dr. Marc Miravitlles, investigador del grup de Pneumologia del #VHIR, explica a El Periódico els principals estudis que es presentaran al congrés de l'@EuroRespSoc que se celebra a Barcelona els pròxims dies. Llegeix l'entrevista completa: https://t.co/sLsEwJsft0 412 views · 1 likes · 0 reposts · 0 replies Open on X →

Vall d'Hebron Institut de Recerca@VHIR_4 Sep

. @vallhebron identifica un nou mecanisme relacionat amb la variabilitat de la malaltia de Dent. 📈 S’ha vist que la proteïna SEC22B està incrementada en l’orina de pacients i, per tant, podria ser usat com a biomarcador. #RecercaPediàtricaVH Més: https://t.co/uMXlQCnGSV https

560 views · 0 likes · 0 reposts · 0 replies Open on X →

Vall d'Hebron Institut de Recerca@VHIR_3 Sep

🔬 #VallHebron desenvoluparà un tractament tòpic contra el lupus eritematós discoide, una malaltia autoimmune de la pell La nova formulació de talidomida ha reduït un 90% les lesions en models animals, sense detectar el fàrmac a la sang. Més info: https://t.co/gXspRLS9dV https:

643 views · 12 likes · 2 reposts · 0 replies Open on X →

Vall d'Hebron Institut de Recerca@VHIR_2 Sep

📢 Busquem persones amb malaltia de Crohn o colitis ulcerosa, i els seus familiars, per participar en un estudi sobre l'impacte de la dieta en la microbiota i el sistema immunitari. 📩 Si vols més informació, contacta'ns! ➡️ https://t.co/GUXy1PzjiU https://t.co/ItiRn4rKse

383 views · 0 likes · 0 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 5 gönderi, 10K–100K takipçi aralığıyla yan yana. hem erişimde hem etkileşimde benzerlerinin altında.

Medyan görüntülenme417bu hesap92410K–100K için medyan

Erişim, %1.81%bu hesap3.62%10K–100K için medyan

Etkileşim, %0.24%bu hesap1.52%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	417	924	0.45×
Erişim (görüntülenme ÷ takipçi)	1.81%	3.62%	0.50×
Etkileşim oranı	0.24%	1.52%	0.16×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3832 Sep

6433 Sep

5604 Sep

412

4177 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.00%2 Sep

2.33%3 Sep

0.18%4 Sep

0.24%

0.48%7 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes78.9%15 in total

Reposts10.5%2 in total

Quotes10.5%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.